Latest Articlesddd
CRISPR, Intellia and Editas CRISPR Therapeutics (CRSP) announced revenues of Q4 2019 that beat analysts’ expectations. …
Cassava Sciences From NEWSWIRE we learned that Cassava Sciences (SAVA), a clinical-stage biotechnology company focusing on Alzheimer’s …
Moderna Therapeutics’ Stock Price Soared, Then Gave Back Its Gains in Two Consecutive Days To begin …
Exelixis Announced Results from its CABOMETYX® Combination with Roche's TECENTRIQ® News announced by Exelixis (EXEL) about …
Regeneron Pharmaceuticals Stock is Rallying Regeneron Pharmaceuticals (REGN) stock outperformed last week gaining over $27. The …
Synopsis The way many bloggers are interpreting the quarterly and yearly biotech companies’ financial results seems …
Nektar Therapeutics NKTR-214: A Blockbuster? Nektar Therapeutics (NKTR) published preclinical data of its immuno-oncology candidate NKTR-214 bempegaldesleukin …
As the Market Seems to Soar Our Eyes Are on the Following Biotech Stocks:
Amgen (AMGN): A …
Gilead Stock Is UP Gilead Sciences' (GILD) provided its antiviral experimental drug remdesivir to physicians for …
Vertex Beats Expectations in 2019 Vertex (VRTX) reported fourth-quarter and full-year 2019 financial results yesterday. The …
Regenxbio, Moderna and Others Regenxbio (RGNX) announced several poster presentations including interim data from its Phase …
Time to Remember Compugen The time has ripened for our readers and biotech investors to remember …
The EMA validated the MAA for the Gilead Investigational CAR T Product for MCL Kite, a Gilead …
Coronavirus On January 7, 2020, a novel coronavirus (2019-nCoV) was identified in humans in Wuhan City, …
A Comprehensive Essay Part 3 In parts 1 and 2 of this comprehensive essay Vertex (VRTX) …
In the NEWS: Coronavirus Yesterday the CDC announced the first US case of coronavirus which has …
Forty Seven On December 21, 2018 Prohost picked Forty Seven (FTSV) at $16.95 adding it to …
Outperforming Prohost Picks January 16, 2020 at 11:30 am EST MRNA Trading at $21.35 UP $1.01 …
Nektar in the NEWS The FDA's Anesthetic and Analgesic Advisory Committee (AADPAC) and Drug Safety and Risk …
A Comprehensive Essay Part 2 In Part 1 of our comprehensive essay series Vertex Pharmaceuticals (VRTX) …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
